Sol-Gel Technologies is a specialty pharmaceutical company that develops and sells topical dermatological drug products in Israel. They offer unique products such as Twyneo and Epsolay which have successfully completed Phase III clinical trials to treat acne vulgaris and papulopustular rosacea respectively. The company has been in operation since 1997 and collaborates with Perrigo.